Hinchcliff, M., Khanna, D., De Lorenzis, E., Di Donato, S., Carriero, A., Ross, R. L., Huang, S., Aren, K. A., Bernstein, E. J., Carns, M., Castelino, F. V., Domsic, R. T., Frech, T. M., Gordon, J. K., Hant, F. N., Shah, A. A., Shanmugam, V. K., Steen, V. D., Assassi, S., & Del Galdo, F. (2025). Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort study. The Lancet Rheumatology. https://doi.org/10.1016/s2665-9913(24)00403-x

Askanase, A. D., D’Cruz, D., Kalunian, K., Merrill, J. T., Navarra, S. V., Cahuzac, C., Cornelisse, P., Murphy, M. J., Strasser, D. S., Trokan, L., & Berkani, O. (2024). Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, double-blind, randomised, placebo-controlled, phase 2 trial. The Lancet Rheumatology. https://doi.org/10.1016/s2665-9913(24)00246-7

Buyon, J. P., Carlucci, P. M., Cuneo, B. F., Masson, M., Izmirly, P., Sachan, N., Brandt, J. S., Mehta-Lee, S., Halushka, M., Thomas, K., Fox, M., Phoon, C. K., Ludomirsky, A., Srinivasan, R., Lam, G., Wainwright, B. J., Fraser, N., & Clancy, R. (2024). Substantiation of trophoblast transport of maternal anti-SSA/Ro autoantibodies in fetuses with rapidly progressive cardiac injury: implications for neonatal Fc receptor blockade. The Lancet Rheumatology. https://doi.org/10.1016/s2665-9913(24)00331-x

Parodis, I., Lindblom, J., Levy, R. A., Zen, M., Cetrez, N., Gomez, A., Oon, S., Henning, C., Khamashta, M., Quasny, H. A., Chauhan, D., Askanase, A., van Vollenhoven, R., & Nikpour, M. (2024). Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials. The Lancet Rheumatology. https://doi.org/10.1016/s2665-9913(24)00162-0